Fuan Pharmaceutical (Group) Co., Ltd. (SHE:300194)
China
· Delayed Price · Currency is CNY 4.320
+0.030 (0.70%)
At close: Mar 10, 2026
SHE:300194 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 5,140 | 5,306 | 5,211 | 4,283 | 6,091 | 5,865 | Upgrade
|
| Market Cap Growth | -3.57% | 1.83% | 21.67% | -29.69% | 3.85% | -11.01% | Upgrade
|
| Enterprise Value | 4,974 | 5,053 | 5,298 | 4,461 | 6,503 | 5,995 | Upgrade
|
| Last Close Price | 4.32 | 4.39 | 4.25 | 3.45 | 4.91 | 4.68 | Upgrade
|
| PE Ratio | 34.44 | 18.96 | 22.47 | 20.93 | - | 28.01 | Upgrade
|
| Forward PE | - | 95.55 | 95.55 | 95.55 | 95.55 | 95.55 | Upgrade
|
| PS Ratio | 3.00 | 2.22 | 1.97 | 1.77 | 2.48 | 2.48 | Upgrade
|
| PB Ratio | 1.15 | 1.21 | 1.26 | 1.09 | 1.58 | 1.29 | Upgrade
|
| P/TBV Ratio | 1.37 | 1.44 | 1.50 | 1.39 | 2.14 | 2.47 | Upgrade
|
| P/FCF Ratio | - | 85.87 | 45.99 | - | - | - | Upgrade
|
| P/OCF Ratio | 31.38 | 17.48 | 15.84 | 12.62 | 23.69 | 36.08 | Upgrade
|
| PEG Ratio | - | 1.43 | 1.43 | 1.43 | 1.43 | 1.43 | Upgrade
|
| EV/Sales Ratio | 2.91 | 2.11 | 2.00 | 1.84 | 2.65 | 2.53 | Upgrade
|
| EV/EBITDA Ratio | 25.54 | 11.34 | 13.49 | 15.70 | 20.20 | 18.06 | Upgrade
|
| EV/EBIT Ratio | - | 20.33 | 28.71 | 44.50 | 44.06 | 34.04 | Upgrade
|
| EV/FCF Ratio | -746.72 | 81.76 | 46.76 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.20 | 0.16 | 0.22 | 0.18 | 0.23 | 0.14 | Upgrade
|
| Debt / EBITDA Ratio | 4.60 | 1.58 | 2.27 | 2.51 | 2.81 | 1.87 | Upgrade
|
| Debt / FCF Ratio | - | 11.42 | 7.88 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.04 | -0.04 | -0.02 | 0.00 | -0.02 | -0.07 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.86 | -0.38 | -0.26 | 0.04 | -0.30 | -0.93 | Upgrade
|
| Net Debt / FCF Ratio | 25.12 | -2.76 | -0.92 | -0.24 | 0.62 | 1.69 | Upgrade
|
| Asset Turnover | 0.28 | 0.40 | 0.45 | 0.42 | 0.42 | 0.44 | Upgrade
|
| Inventory Turnover | 1.46 | 1.51 | 1.79 | 1.58 | 1.53 | 1.51 | Upgrade
|
| Quick Ratio | 1.39 | 0.95 | 1.16 | 0.90 | 1.10 | 1.24 | Upgrade
|
| Current Ratio | 2.18 | 1.68 | 1.78 | 1.50 | 1.62 | 1.84 | Upgrade
|
| Return on Equity (ROE) | 3.21% | 6.51% | 5.79% | 5.14% | -14.48% | 4.82% | Upgrade
|
| Return on Assets (ROA) | 0.05% | 2.60% | 1.95% | 1.08% | 1.58% | 2.06% | Upgrade
|
| Return on Invested Capital (ROIC) | 0.11% | 5.35% | 3.72% | 2.60% | 3.68% | 4.01% | Upgrade
|
| Return on Capital Employed (ROCE) | 0.10% | 5.20% | 3.90% | 2.20% | 3.30% | 3.60% | Upgrade
|
| Earnings Yield | 2.81% | 5.27% | 4.45% | 4.78% | -4.87% | 3.57% | Upgrade
|
| FCF Yield | -0.13% | 1.17% | 2.17% | -1.02% | -2.56% | -3.10% | Upgrade
|
| Dividend Yield | 0.93% | 1.14% | 1.18% | 1.45% | - | 1.07% | Upgrade
|
| Payout Ratio | 72.73% | 30.09% | 40.53% | 13.73% | - | 34.73% | Upgrade
|
| Buyback Yield / Dilution | 6.03% | 4.46% | -1.40% | -1.34% | -2.10% | 0.70% | Upgrade
|
| Total Shareholder Return | 6.96% | 5.60% | -0.22% | 0.11% | -2.10% | 1.76% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.